全文获取类型
收费全文 | 9865篇 |
免费 | 1040篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 104篇 |
儿科学 | 274篇 |
妇产科学 | 252篇 |
基础医学 | 1400篇 |
口腔科学 | 308篇 |
临床医学 | 1264篇 |
内科学 | 1947篇 |
皮肤病学 | 104篇 |
神经病学 | 908篇 |
特种医学 | 294篇 |
外国民族医学 | 3篇 |
外科学 | 1261篇 |
综合类 | 201篇 |
一般理论 | 10篇 |
预防医学 | 1152篇 |
眼科学 | 106篇 |
药学 | 710篇 |
中国医学 | 4篇 |
肿瘤学 | 644篇 |
出版年
2022年 | 69篇 |
2021年 | 119篇 |
2020年 | 94篇 |
2019年 | 142篇 |
2018年 | 155篇 |
2017年 | 118篇 |
2016年 | 119篇 |
2015年 | 164篇 |
2014年 | 237篇 |
2013年 | 296篇 |
2012年 | 468篇 |
2011年 | 527篇 |
2010年 | 257篇 |
2009年 | 286篇 |
2008年 | 428篇 |
2007年 | 449篇 |
2006年 | 445篇 |
2005年 | 448篇 |
2004年 | 397篇 |
2003年 | 371篇 |
2002年 | 367篇 |
2001年 | 361篇 |
2000年 | 330篇 |
1999年 | 266篇 |
1998年 | 116篇 |
1997年 | 118篇 |
1996年 | 101篇 |
1995年 | 118篇 |
1994年 | 102篇 |
1993年 | 85篇 |
1992年 | 212篇 |
1991年 | 220篇 |
1990年 | 216篇 |
1989年 | 193篇 |
1988年 | 181篇 |
1987年 | 178篇 |
1986年 | 204篇 |
1985年 | 190篇 |
1984年 | 134篇 |
1983年 | 123篇 |
1982年 | 80篇 |
1981年 | 81篇 |
1979年 | 135篇 |
1978年 | 120篇 |
1977年 | 95篇 |
1976年 | 89篇 |
1975年 | 73篇 |
1974年 | 87篇 |
1973年 | 93篇 |
1972年 | 78篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
The data with which Student illustrated the application of his famous distribution are examined from a number of aspects. Central to the discussion is the within-patient clinical trial at Kalamazoo whose results were published by Cushny and Peebles and misquoted by Student and Fisher. This trial is discussed from historical, pharmacological and statistical perspectives. Student's and Fisher's analyses and a more modern analysis by Preece are considered as is Cushny's and Peebles's interpretation. Brief biographies of the five physicians involved in running the trial are presented. 相似文献
32.
33.
Malcolm E. Richardson Samuel Menahem James L. Wilkinson 《International journal of cardiology》1991,30(3):351-353
In this report, we give details of two families in which fixed subaortic stenosis was found in more than one member. It is rare for this entity to show familial incidence. 相似文献
34.
Laurie M. Lomasney John F. Madden Wagdy S. Rizk Lawrence W. Hedlund Salutorio Martinez Robert E. Coleman William J. Richardson H. Dirk Sostman 《Journal of magnetic resonance imaging : JMRI》1994,4(3):441-449
Magnetic resonance (MR) imaging may be a noninvasive method for assessing perfusion of vascularized bone grafts placed for treatment of avascular necrosis. One proximal femur of seven beagles was devascularized, with insertion of a vascularized fibular graft. MR imaging at 1 week (seven dogs) and 6 weeks (five dogs) after surgery included pre- and postcontrast spin-echo sequences, unenhanced twodimensional time-of-flight (TOF) vascular imaging, and dynamic gradient-echo imaging during infusion of gadolinium. Relative signal intensity values of selected regions obtained from the dynamic gradientecho images were plotted as percent enhancement versus time. In the operated hip, MR imaging did not show enhancement in six of seven femoral heads and greater trochanters at 1 week after surgery, with similar results after 6 weeks. MR imaging of fibular grafts 6 weeks after surgery showed an initial rapid increase in enhancement and a subsequent slower increase in five of five dogs, although no enhancement was seen in six of seven dogs at 1 week. These findings contrasted with a rapid initial increase in enhancement followed by slow decline in non-operated hips. Two-dimensional TOP imaging did not show the vascular pedicle of the graft in any dog. Findings of radionuclide bone scanning performed 1 week after surgery were consistent with devascularization of the operated femur and fibular graft. However, tetracycline distribution and histologic findings confirmed the viability of five of five grafts within the devascularized femurs 6 weeks after surgery. Thus, dynamic contrast-enhanced MR imaging at 6 weeks after surgery is valuable for assessing vascular bone graft perfusion, while similar imaging at 1 week may suggest otherwise. 相似文献
35.
36.
37.
A single case of bilateral congenital mydriasis is described. A review of the literature is presented and possible modes of inheritance are discussed. 相似文献
38.
M. P. Muller S. E. Richardson A. McGeer L. Dresser J. Raboud T. Mazzulli M. Loeb M. Louie 《European journal of clinical microbiology & infectious diseases》2006,25(4):230-237
The clinical presentation of SARS is nonspecific and diagnostic tests do not provide accurate results early in the disease course. Initial diagnosis remains reliant on clinical assessment. To identify features of the clinical assessment that are useful in SARS diagnosis, the exposure status and the prevalence and timing of symptoms, signs, laboratory and radiographic findings were determined for all adult patients admitted with suspected SARS during the Toronto SARS outbreak. Findings were compared between patients with laboratory-confirmed SARS and those in whom SARS was excluded by laboratory or public health investigation. Of 364 cases, 273 (75%) had confirmed SARS, 30 (8%) were excluded, and 61 (17%) remained indeterminate. Among confirmed cases, exposure occurred in the healthcare environment (80%) or in the households of affected patients (17%); community or travel-related cases were rare (<3%). Fever occurred in 97% of patients by the time of admission. Respiratory findings including cough, dyspnea and pulmonary infiltrates evolved later and were present in only 59, 37 and 68% of patients, respectively, at admission. Direct exposure, fever on the first day of illness, and elevated temperature, pulmonary infiltrates, lymphopenia and thrombocytopenia at admission were associated with confirmed cases. Rhinorrhea, sore throat, and an elevated neutrophil count at admission were associated with excluded cases. In the absence of fever or significant exposure, SARS is unlikely. Other clinical, laboratory and radiographic findings further raise or lower the likelihood of SARS and provide a rational basis for estimating the likelihood of SARS and directing initial management. 相似文献
39.
Deborah W. Knapp Ralph C. Richardson Gerald D. Bottoms Robert Teclaw Thomas C. K. Chan 《Cancer chemotherapy and pharmacology》1992,29(3):214-218
Summary Piroxicam, a nonsteroidal antiinflammatory drug, was given to 62 dogs bearing naturally occurring tumors in a phase I clinical trial. Dose escalation was performed, with oral doses ranging from 0.5 mg/kg every 48 h (q48h) to 1.5 mg/kg q48h being tested. Dose-limiting gastromestinal irritation/ulceration occurred in all four animals that received 1.5 mg/kg q48h. The maximum tolerated dose was 1 mg/kg q48h. Subclinical renal papillary necrosis occurred in two dogs (initial dosages, 1 and 1.5 mg/kg q48h, respectively). Following dose escalation, an additional group of dogs was treated with 0.3 mg/kg piroxicam q24h per os, the accepted canine dosage prior to this trial. Inclusion of this treatment group enabled evaluation of the toxicity of and tumor response to a daily dosage regimen. No complete remissions occurred in this trial. Partial remission was documented in three of ten dogs exhibiting transitional-cell carcinoma, in three of five animals bearing squamous-cell carcinoma, in one of three dogs displaying mammary adenocarcinoma, and in the one dog that exhibited a transmissible venereal tumor. The results of this study support the additional evaluation of piroxicam in a phase II clinical trial in dogs bearing naturally occurring tumors.This investigation was supported by Pfizer Inc. 相似文献
40.
Diarrhea has been reported as an early, mild, and uncommon complication of carbamazepine (CBZ) therapy. We report three cases of intractable diarrhea induced by CBZ necessitating discontinuation of the drug. 相似文献